期刊文献+

活化血浆凝固时间对免疫性血小板减少症患者出血的风险评估 被引量:4

Testing of activated plasma clotting time to assess the bleeding diathesis of immune thrombocytopenia
下载PDF
导出
摘要 目的:探讨活化血浆凝固时间(APCT)对免疫性血小板减少症(ITP)患者出血的风险评估。方法:2008年4月至2013年7月在我院血液科住院的ITP患者共128名。抽取患者静脉血,测定血小板计数和APCT。将患者分为血小板计数〈30×10^9/L组和血小板计数(30~79)×10^9/L组。将APCT与Khellaf出血评分结果进行相关性分析,探讨APCT预示ITP患者血小板减少所致出血的敏感性、特异性、假阳性率及其与Khellaf出血评分的相关性。结果:APCT≥90s为界点值,对预示血小板减少所致出血的敏感性为100%,特异性为91.3%,假阳性率为8.69%,假阴性率为0%。在血小板计数〈30×10^9/L组中,APCT与Khellaf出血评分数值呈直线型正相关(r=0.968,P=0.013)。在血小板计数(30~79×)10^9/L组中,APCT的变化与Khellaf出血评分亦具有正相关性(r=0.764,P=0.01)。结论:APCT具有良好的敏感性和特异性,是评估ITP患者出血风险的良好指标。 To investigate the value of activated plasma clotting time (APCT) for assessing the bleeding diathesis of immune thrombocytopenia. Methods: There were one hundred and twenty-eight patients of diopathic immune thrombocytopenia. Taking the patient's venous blood, the patient's blood platelet count and activated plasma clotting time were determined. The patients were devided into two groups by platelet count, one group's platelet count was lower than 30 × 10^9/L, and the other group's platelet count was 30 ×10^9/L - 79 × 10^9/L.Acorrding to the test, we could get APCT. By analyzing APCT and Khellaf bleeding score, we could receive that APCT and Khellaf bleeding score results had linear correlation. Results: We set APCT critical point was high than ninety seconds. The sensibility to assess the ITP patient's bleeding was 100%, the specificity is 91.3% and the false positive rate 8.69%. In the group's platelet count was lower than 〈30 × 10^9/L, we could receive that APCT and Khellaf bleeding score results had linear positive correlation, P=0.013, r=-0.968. In the group's platelet count was about 30 × 10^9/L - 79 × 10^9/L, we could receive that APCT and Khellaf bleeding score results had correlation,P=0.01, r=0.764. Conclusion: APCT has a good sensibility and specificity. It is a good predictive index to assessing the bleeding of ITP.
出处 《温州医学院学报》 CAS 2014年第3期197-200,共4页 Journal of Wenzhou Medical College
基金 温州市科技局科研基金资助项目(Y20080210)
关键词 免疫性血小板减少症 活化血浆凝固时间 血小板计数 Khellaf出血评分系统 immune thrombocytopenia activated plasma clotting time blood platelet count Khellaf bleed-ing score system
  • 相关文献

参考文献10

  • 1Schwartz KA, Schwartz DE, Pittsley RA, et al. A new method for measuring inhibition of platelet function by nonsteroi- dal antiinflammatory drugs[J]. Lab Clin Med, 2002. 139(4): 227-233.
  • 2Khellaf M, Michel M, Schaeffer A, et al. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count[J]. Haematologica, 2005, 90(6): 829-832.
  • 3中华医学会血液学分会血栓与止血组学组.成人ITP诊断与治疗中国专家共识(2012)[J].中华血液学杂志,2012,33(111:975-977.
  • 4王琳,侯明.原发免疫性血小板减少症出血评分系统临床应用分析[J].中华血液学杂志,2012,33(6):499-501. 被引量:8
  • 5Xiao HY, Matsubayashi H, Bonderman DP, et al. Genera- tion of annexinV-positive platelets and shedding of mi- croparticles with stimulus-dependent procoagulant activity during storage of platelets at 4 C [J]. Transfusion, 2000, 40 (4): 420-427.
  • 6Cohen YC, Djulbegovic B, Shamai-Lubovitz O, et al. The bleeding risk and natural history of idiopathic thrombocy-.topenic purpura in patients with persistent low platelet counts[J]. Arch Intern Med, 2000, 160(11): 1630-1638.
  • 7Severinsen MT, Engebjerg MC, Farkas DK, et al. Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia:a Danish population-based co- hort study[J]. Br J Haematol, 2011, 152(3): 360-362.
  • 8王婧,袁晋青.血小板功能检测与临床应用研究进展[J].心血管病学进展,2012,33(6):709-713. 被引量:11
  • 9陈慧,杨军军,郑美琴,卓曼玉.特发性血小板减少性紫癜患者凝血功能的变化[J].临床内科杂志,2005,22(6):423-423. 被引量:1
  • 10金汉珍 黄德珉 官希吉.实用新生儿学[M].北京:人民卫生出版社,2002.194.

二级参考文献29

  • 1Buchanan GR, Adix L. Grading of hemorrhage in children with id- iopathic thrombocytopenic purpura. J Pediatr,2002,141:683-688.
  • 2Khellaf M, Michel M, Schaeffer A, et al. Assessment of a thera- peutic strategy for adults with severe autoimmune thromhocytopenic purpura based on a bleeding score rather than platelet count. Haematologica, 2005,90:829-832.
  • 3Burros IA, Bussel JB. Intracranial hemorrhage in immune thrombo- cytopenic purpura: a retrospective analysis. J Pediatr Hematol On- col, 2003, 25:660-664.
  • 4Page LK, Psaila B, Provan D, et al. The immune thrombocytope- nic purpura (ITP) bleeding score : assessment of bleeding in pa- tients with ITP. Br J Haematol,2007 ,138 :245-248.
  • 5Fogarty PF, Tarantino MD, Brainsky A, et al. Selective validation of the WHO Bleeding Scale in patients with chronic immune throm- bocytopenia. Curt Med Res Opin, 2012, 28:79-87.
  • 6Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer, 1981, 47:207-214.
  • 7Crosby WH. Wet purpura, dry purpura. JAMA, 1975, 232:744- 745.
  • 8Hanss M, Ville D, Dechavanne M. Increased plasma tissuetype plasminogen activator levels in patients with chronic thrombocytopenia. Haemostasis. 1990, 20:341 - 346.
  • 9Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antip]atelet therapy in various categories of patients[ J ], BMJ, 1994,308:81-106.
  • 10CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of iscbaemic events (CAPRIE) [ J ]. Lancet, 1996, 348 : 1329-1339.

共引文献125

同被引文献30

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部